Immuron share price logo

Immuron

NASDAQ: IMRN

$0.90

+0.05

(+5.86%)

as on

Immuron Stock Performance

as on November 21, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.81
    $0.87
    downward going graph

    9.98%

    Downside

    -3.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.68
    $1.99
    downward going graph

    24.82%

    Downside

    121.16%

    Upside

    downward going graph

Immuron share price movements today

Previous Close
$0.85
Open
$0.85
Volume
142.3K
Market Cap
$6.9M
Day's Low - High
$0.81 - $0.87
52 Week Low - High
$0.68 - $1.99

Immuron Historical Returns

1 Month Return
-7.24 %
3 Month Return
-19.66 %
1 Year Return
-46.44 %
3 Year Return
-52.53 %
5 Year Return
-73.84 %

Immuron Stock Fundamentals & Key Indicators

Check Immuron market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.9M

EPS (TTM)

-0.51

Dividend Yield

0.00%

PE Ratio (TTM)

-2.87

Industry PE ratio

-4.99

PEG Ratio

-0.05

Return On Equity TTM

-31.88%

Immuron vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immuron with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$6.9M-73.84%-2.8764.50%0.00%
Neutral$80.7B-26.07%-28.1528.00%0.00%
StrongBuy$45.7BNA65.0988.39%0.00%
StrongBuy$132.0B181.62%33.2585.53%0.00%
Buy$95.5B41.06%19.6585.77%0.41%

Stock Returns calculator for Immuron Stock including INR - Dollar returns

The Immuron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Immuron investment value today

Current value as on today

₹55,369

Returns

-₹44,631

(-44.63%)

Returns from Immuron Stock

-₹46,440 (-46.44%)

Dollar Impact

₹1,810 (+1.81%)

Indian Investors' Interest in Immuron Stock

Search interest for Immuron Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Immuron Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Jun 2026
Total Revenue
0
2
1
2
1
3
1
3
4
3
Gross Profit
0
1
0
1
1
2
1
2
2
2
Operating Income
0
-2
-1
-3
-1
-2
-1
-2
-2
-2
EBITDA
0
-2
-1
-3
-1
-2
-1
-2
-2
-2
Interest Expense
0
0
-
0
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
-
-
Income Before Tax
0
-2
-2
-4
-1
-2
-1
-2
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
0
0
Net Income
0
-2
-2
-4
-1
-2
-1
-2
-1
-1
Net Profit Margin
107.46%
67.09%
68.95%
68.95%
66.52%
66.52%
64.02%
64.02%
63.42%
65.78%

Immuron Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
1
1
2
2
0
0
1
4
7
7
Gross Profit
0
1
1
1
0
0
1
3
4
4
Operating Income
-8
-2
-4
-2
-8
-2
-3
-5
-5
-4
EBITDA
-8
-3
-4
-3
-7
-3
-3
-5
-5
-4
Interest Expense
0
0
-
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-6
-3
-4
-2
-8
-2
-3
-6
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
0
Net Income
-6
-3
-4
-2
-8
-2
-3
-6
-5
-3
Net Profit Margin
66.05%
68.40%
71.49%
72.65%
-456.22%
68.41%
96.42%
68.06%
65.39%
64.50%

Immuron Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Jun 2026
Net Income
-1
-1
-2
-2
-1
-2
-1
-2
-1
-1
Operating Cash Flow
-1
-1
-1
-1
-1
-3
-1
-2
-2
0
Investing Cash Flow
0
0
0
0
0
0
-1
-2
2
0
Financing Cash Flow
0
0
0
0
0
0
0
0
6
0
Change in Cash
-1
-1
-15
-15
-
-2
-
-2
7
0

Immuron Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-6
-3
-3
-2
-6
-2
-3
-6
-5
-3
Operating Cash Flow
-7
-3
-1
-3
-3
-3
-2
-5
-6
-2
Investing Cash Flow
0
0
0
0
0
0
-2
0
-2
2
Financing Cash Flow
8
4
1
1
19
0
0
0
0
6
Change in Cash
1
0
0
-1
21
-2
-4
-5
-8
6

Global Institutional Holdings in Immuron

Check out the Institutions with significant holdings in Immuron.

Funds
Holdings
Shares Held
BlackRock, Inc.
0.00%
225

Immuron News & Key Events

  • img

    Today's Timeline - 10 November

    Tue, 10:51 PM

    -

    Immuron engages LifeSci Capital as exclusive financial advisor for strategic initiatives to maximize shareholder value.

Insights on Immuron

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IMRN stock has moved up by 2.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 149.5% return, outperforming this stock by 199.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 722.1% return, outperforming this stock by 768.5%

About Immuron

Immuron Limited, an Australian biopharmaceutical firm founded in 1994 and headquartered in Carlton, is dedicated to the exploration, advancement, and worldwide commercialization of polyclonal antibodies. Operating across two divisions—Research and Development, and Hyperimmune Products—the company serves markets in Australia, Israel, Canada, the United States, and other international regions. Its current product portfolio includes Travelan, an over-the-counter remedy aimed at reducing the likelihood of travelers' diarrhea and minor gastrointestinal complaints, which also functions as a dietary supplement for digestive well-being and gut protection. Another offering, Protectyn, is an immune supplement formulated to bolster healthy digestive function and liver support. Beyond its commercialized products, Immuron is actively progressing several pipeline candidates. Travelan (IMM-124E) is currently undergoing a Phase III registration trial in the United States for the prevention of travelers' diarrhea, alongside a Phase II field trial for the same indication, and has demonstrated antiviral efficacy against SARS-CoV-2. Concurrently, IMM-529 is in Phase I/IIa clinical trials, targeting patients with recurrent Clostridium difficile infections. The company has also established key research alliances, including an agreement with the Naval Medical Research Center to develop and clinically evaluate a therapeutic agent against Campylobacter and enterotoxigenic Escherichia coli infections, and a collaborative effort with the Walter Reed Army Institute of Research to create an oral treatment for shigellosis.
OrganisationImmuron
Headquarters62 Lygon Street, Carlton, VIC, 3053, AU
IndustryBiotechnology
CEOSteven George Lydeamore

Key Management of Immuron

Name

Title

Mr. Steven George Lydeamore CPA, M.B.A.

Chief Executive Officer

Dr. Jerry Kanellos Ph.D.

Chief Scientific Officer

Mr. Flavio Palumbo

Chief Commercial Officer

Mr. Aaron Laurita

Chief Financial Officer

Mr. David Lyon

Head of Marketing

Ms. Olga Smejkalova

Company Secretary

FAQs

What is Immuron share price today?

Immuron share price today is $0.90 as on at the close of the market. Immuron share today touched a day high of $0.87 and a low of $0.81.

What is the 52 week high and 52 week low for Immuron share?

Immuron share touched a 52 week high of $1.99 on and a 52 week low of $0.68 on . Immuron stock price today i.e. is closed at $0.90,which is 54.78% down from its 52 week high and 33.01% up from its 52 week low.

What is Immuron's market capitalisation today?

Immuron market capitalisation is $0.00T as on .

How to invest in Immuron Stock (IMRN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immuron on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Immuron Stock (IMRN) from India?

Indian investors can start investing in Immuron (IMRN) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Immuron stock (as per the Rupee-Dollar exchange rate as on ). Based on Immuron share’s latest price of $0.90 as on November 21, 2026 at 8:45 am IST, you will get 11.1136 shares of Immuron. Learn more about fractional shares .

What are the returns that Immuron has given to Indian investors in the last 5 years?

Immuron stock has given -73.84% share price returns and 25.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?